Clinical Trial Update: Effect of Sodium-glucose Cotransporter-2 Inhibitor in Cellular Senescence in Patients With Cardiovascular Diseases or Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the effect of sodium-glucose cotransporter-2 inhibitors on cellular senescence in patients with cardiovascular disease …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: Yonsei University | Conditions: Diabetes Mellitus, Cellular Senescence | Phase 4 | Status: UNKNOWN